Group 1 - Several new stocks have recently been listed on the Hong Kong stock market, including Jiaxin International Resources, Shuangdeng Co., Yinnuo Pharmaceutical-B, and Zhonghui Biotechnology-B, which performed well on their debut [2] - On September 17, a new stock named Health 160 was listed, opening over 150% higher and reaching a peak increase of 174%, before settling at a gain of 146.43% at the time of reporting [3] - Health 160's public offering was highly subscribed, with a subscription rate of 751.77 times, resulting in 3.36475 million shares being allocated for public sale, which is about 10% of the total shares offered [4][5] Group 2 - Health 160 is a leading wholesaler of medical health products and a digital healthcare service provider, offering a range of medical health products and comprehensive digital healthcare solutions [4] - As of March 31, 2025, Health 160 has connected over 44,600 healthcare institutions, including more than 14,400 hospitals, and has registered 55.2 million personal users on its platform [6] - The company's revenue for the years 2022 to 2024 was 526 million, 629 million, and 621 million RMB respectively, with losses of 120 million, 106 million, and 108 million RMB during the same periods [6]
【IPO追踪】又一只新股上市！健康160首日高开逾150%